Nine Hypericum species (H. barbatum, H. hirsutum, H. linarioides, H. olympicum, H. perforatum, H. rochelii, H. rumeliacum, H. tetrapterum and H. umbellatum) collected in Serbia were assayed for inhibitory potential against xanthine oxidase in vitro, on the commercial enzyme, and compared with allopurinol. Seven studied Hypericum species (H. barbatum, H. rochelii, H. rumeliacum, H. umbellatum, H. perforatum, H. tetrapterum and H. olympicum) inhibit commercial xanthine oxidase with an IC50 below 100 µg/mL. H. barbatum exerted the most potent inhibitory effect (IC50 = 31.84 ± 6.64 µg/mL), followed closely by H. perforatum (IC50 = 37.12 ± 4.06 µg/mL). 
I NT ROD U CT I ON
Xanthine oxidase (XO) is a validated target for therapeutic treatment of gout, hyperuricemia and associated conditions, with a few XO inhibitors present on the market (1) . Levels of XO in plasma are enhanced also in ischemia-reperfusion injury, hemorrhagic shock, cholecystis, hypercholesterolemia, adult respiratory distress syndrome, carcinogenesis, which provides additional indications where XO inhibitors may exert their therapeutic potential (2) .
Secondary metabolites from plants have a long tradition of being used as therapeutics in medicine (3) . Hypericum species are traditionally used as medicinal plants all over the world (4) . H. perforatum (St. John's wort) is one of the best chemically determined species. The investigation of Hypericum species have increased over the years due to evidenced bioactivities of compounds found in H. perforatum. Chemically, naphthodianthrones, primarily hypericin and pseudohypericin, phloroglucinol derivatives, especially hyperforin, and flavonoids quercetin, quercitrin, hyperoside and rutin represent the main constituents in the Hypericum species (5).
Continuing our research on the chemical composition (6) (7) (8) (9) (10) (11) and pharmacological activities (11) (12) (13) (14) of Hypericum species, in the present study extracts of Table 1 contains data on the identity of nine assayed Hypericum species, their taxonomic placement within sections of the genus Hypericum, voucher numbers of the deposited herbarium specimens (Herbarium Moesicum Doljevac, Serbia), collection period and locality (15) . Collection was done in the blooming stage. 
MATERIALS AND METHODS

Plant material
Preparation of plant extracts
The extractions were performed using 3 g dry plant material and 30 mL of ethanol, using an indirect sonication method. Sonications lasted 30 min, using a Bandelin Sonorex Digital 10 P apparatus (Bandelin). At the end of extraction, filtration was done in order to separate the extracts from the residual plant material. After washing the residues with 15 mL of ethanol, the filtrates were combined and evaporated using a rotary vacuum evaporator Büchi® Rotavapor® R-210 (Büchi). Dry extracts were then dissolved in dimethyl sulfoxide (DMSO) and stored at -20 ° C until measurement.
Evaluation of xanthine oxidase inhibition
Inhibition of XO was evaluated in vitro on the commercial bovine milk enzyme (Sigma-Aldrich), by spectrophotometric measurement of uric acid formation at 293 nm. The assay was performed in a series of testtubes (total volume 2150 μL) prepared in the following order: i) Test samples: 0.01 units of XO, one of the studied extracts diluted in DMSO (purity ≥ 99.5%; Sigma-Aldrich) (the final concentration of DMSO in the assay was 4.65 % v/v), 232.5 μM of xanthine (purity ≥ 99.5%; Sigma-Aldrich), and 46.5 mM TRIS-HCl buffer (pH 7.8); ii) Solvent control samples: the same amount of XO, appropriate amount of DMSO, xanthine and TRISHCl buffer; iii) Control samples: the same amount of XO, xanthine and TRIS-HCl buffer adjusted to the same volume. Blank samples were prepared for each group (iiii). The tubes were incubated at 37 °C for 15 min, and after that the reaction was stopped by adding 100 μL of perchloric acid. The difference in absorbance, calculated as a percent change of the control with appropriate amount of DMSO, which correlates to uric acid formation, was used for the determination of the percentage of enzyme inhibition. DMSO, at a final concentration of 4.65 % v/v, did not affect the enzyme assay. The evaluation of XO inhibitory potential of all samples was performed at the concentrations of 100 μg/mL. Extracts exerting inhibition greater than 50 % at 100 μg/mL were tested in a broader concentration range in order to allow calculation of IC50 values. Each IC50 curve was generated using four concentrations of inhibitor producing an inhibition. Positive control was allopurinol and experiments were performed in triplicate.
RE S U LT S A ND DI SCU SSI ON
Seven of the nine studied Hypericum species inhibit commercial bovine milk XO with an IC50 below 100 μg/mL (Table 2 ). H. barbatum showed the most potent inhibitory effect (IC50 = 31.84 ± 6.64 μg/mL). Allopurinol, an approved XO inhibitor, exhibited stronger inhibitory potential (IC50 = 0.20 ± 0.03 μg/mL) than studied Hypericum species. The extracts of Hypericum species belonging to the section Taeniocarpium did not inhibit commercial bovine milk XO with an IC50 below 100 μg/mL. (6) , which is in agreement with the study of Kitanov (18), who reported that the content of total hypericins in H. barbatum is by 2.4 times higher than in H. perforatum. The potent inhibitory effect of H. barbatum against XO activity may be related to the high level of hypericin. Also, H. perforatum showed a very potent inhibitory effect against XO with an IC50 value of 37.12 ± 4.06 μg/mL. The highest content of hyperforin was found in H. perforatum (6) . 
CONCL U S I ON
